Skip to main content
. 2013 Nov 25;8(11):e81493. doi: 10.1371/journal.pone.0081493

Table 2. Clinical phenotype of afected mutation carriers.

Patient, (gender) Clinical phenotype
Proband, (F) Syncope, Ventricular tachycardia and fibrillation, bradycardia and paroxysmal atrial fibrillation.
II:4 (F) Abnormal basal ECG. Development of type 1 BrS after flecainide test.
II:8 (F) Permanent atrial fibrillation
III:1 (M) Abnormal basal ECG. Development of type 1 BrS after flecainide test.
III:6 (M) Syncope.

BrS: Brugada Syndrome. ECG: Electrocardiogram, F: female, M: male.